PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.\', \'Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Pediatrics, Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA, USA.\', \'Department of Medicine, University of California at San Francisco School of Medicine, San Francisco, CA, USA.\', \'Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA. rafick.sekaly@emory.edu.\', \'Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA. rafick.sekaly@emory.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41590-022-01130-4
?:doi
?:hasPublicationType
?:journal
  • Nature immunology
is ?:pmid of
?:pmid
?:pmid
  • 35210622
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 14.007
?:rankingScore_hIndex
  • 336
?:title
  • Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all